BlackRock Institutional Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.46B Buy
21,253,432
+540,647
+3% +$60.2M 0.36% 46
2016
Q3
$2.17B Buy
20,712,785
+471,143
+2% +$51M 0.34% 50
2016
Q2
$2B Buy
20,241,642
+117,543
+0.6% +$12.2M 0.32% 54
2016
Q1
$2.01B Sell
20,124,099
-98,716
-0.5% -$10.2M 0.33% 53
2015
Q4
$2.42B Sell
20,222,815
-153,021
-0.8% -$17.7M 0.4% 46
2015
Q3
$2.2B Sell
20,375,836
-296,641
-1% -$36.8M 0.38% 49
2015
Q2
$2.39B Sell
20,672,477
-572,591
-3% -$65.5M 0.38% 47
2015
Q1
$2.45B Buy
21,245,068
+79,276
+0.4% +$9.47M 0.38% 50
2014
Q4
$2.37B Sell
21,165,792
-293,498
-1% -$31M 0.38% 46
2014
Q3
$2.03B Sell
21,459,290
-294,104
-1% -$26.5M 0.34% 51
2014
Q2
$1.87B Sell
21,753,394
-416,058
-2% -$31.6M 0.31% 57
2014
Q1
$1.55B Buy
22,169,452
+630,482
+3% +$49.9M 0.27% 72
2013
Q4
$1.82B Sell
21,538,970
-1,474,600
-6% -$117M 0.32% 55
2013
Q3
$1.77B Sell
23,013,570
-522,524
-2% -$36.6M 0.34% 51
2013
Q2
$1.38B Buy
+23,536,094
New +$1.42B 0.28% 63

Other funds holding CELG

BlackRock Institutional Trust's CELG Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Celgene Corp (CELG) stake by 2.6% in Q4 2016, buying an estimated $60.2M and bringing the position to 21,253,432 shares worth $2.46B. The position accounts for 0.36% of the portfolio, ranked #46.

BlackRock Institutional Trust first reported a position in CELG in Q2 2013 and has held it in 15 quarters since. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • BlackRock Institutional Trust held 21,253,432 shares of Celgene Corp worth $2.46B as of Q4 2016.
  • BlackRock Institutional Trust bought 540,647 Celgene Corp shares in Q4 2016, an estimated $60.2M.
  • Celgene Corp made up 0.36% of BlackRock Institutional Trust's portfolio in Q4 2016, its #46 holding.
  • BlackRock Institutional Trust first reported a position in Celgene Corp in Q2 2013 and has held it in 15 quarters since.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.